Published in Pathol Res Pract on April 01, 1994
Hamartoma of the breast: a clinicopathological review. J Clin Pathol (2002) 1.10
Ductal carcinoma in situ arising in mammary hamartoma. J Clin Pathol (2002) 0.89
Myoid hamartoma of the breast that proved difficult to diagnose: a case report. World J Surg Oncol (2012) 0.87
Breast hamartoma: a clinicopathologic analysis of 27 cases and a literature review. Clinics (Sao Paulo) (2014) 0.86
Myofibroblastoma arising in mammary hamartoma: a case report. Patholog Res Int (2010) 0.85
A rare case of recurrent myoid hamartoma mimicking malignancy: imaging appearances. Korean J Radiol (2010) 0.82
"Breast within a breast" sign: Mammary hamartoma. Med J Armed Forces India (2015) 0.75
Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases. Breast J (2016) 0.75
Giant breast hamartoma in a 41-year-old female: A case report and literature review. Oncol Lett (2015) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Management of nevus spilus. Pediatr Dermatol (1996) 3.21
VCAM (IGSF) adhesion molecule expression in breast carcinomas detected by automated and quantitative immunocytochemical assays. Hum Pathol (1998) 1.59
Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas. Br J Cancer (2001) 1.55
Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition? Int J Cancer (1995) 1.51
Asomatognosia P. Bonnier. L'aschématie. Revue Neurol 1905;13:605-9. Epilepsy Behav (2009) 1.44
[Impalpable cancers of the breast. Histological and immunohistochemical study]. Arch Anat Cytol Pathol (1994) 1.40
Unfading acral microlivedo. A discrete marker of thrombotic skin disease associated with antiphospholipid antibody syndrome. J Am Acad Dermatol (1991) 1.39
Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer (2010) 1.37
Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer (1997) 1.29
Age as a prognostic factor in breast cancer: relationship to pathologic and biologic features. Int J Cancer (1995) 1.27
HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer (2013) 1.17
Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J Natl Cancer Inst (1994) 1.05
Multiple lateral meningoceles, distinctive facies and skeletal anomalies: a new case of Lehman syndrome. Clin Dysmorphol (1995) 1.04
CD31 quantitative immunocytochemical assays in breast carcinomas. Correlation with current prognostic factors. Am J Clin Pathol (1995) 1.03
Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections. Cancer Res (1988) 1.00
Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). Br J Cancer (2004) 1.00
bcl-2 automated and quantitative immunocytochemical assays in breast carcinomas: correlation with 10-year follow-up. J Clin Oncol (1998) 0.98
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. Br J Cancer (2007) 0.98
The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol (1991) 0.96
Clinical and biologic prognostic factors in breast cancer diagnosed during postmenopausal hormone replacement therapy. Obstet Gynecol (1995) 0.95
Electron-beam therapy in scleredema adultorum with associated monoclonal hypergammaglobulinaemia. Br J Dermatol (1994) 0.94
A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis. Eur J Surg Oncol (2008) 0.94
Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80. J Allergy Clin Immunol (1983) 0.93
c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse. Eur J Cancer (1992) 0.93
Variations in the risk of breast cancer associated with a family history of breast cancer according to age at onset and reproductive factors. J Clin Epidemiol (1993) 0.92
CD31/PECAM automated and quantitative immunocytochemical assays in breast carcinomas: correlation with patient follow-up. Am J Clin Pathol (1997) 0.92
Reduced E-cadherin immunohistochemical expression in node-negative breast carcinomas correlates with 10-year survival. Am J Clin Pathol (1998) 0.92
E-cadherin quantitative immunocytochemical assays in breast carcinomas. J Pathol (1997) 0.90
[Liposarcoma of the pancreas. Study of a case including ultrastructure]. Ann Anat Pathol (Paris) (1979) 0.90
Granulomatous mycosis fungoides. Eur J Dermatol (1999) 0.89
Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Hum Pathol (1997) 0.89
Inflammatory carcinoma of the breast. Eur J Gynaecol Oncol (1992) 0.87
Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders. Am J Pathol (1988) 0.87
Reproductive factors and breast cancer risk. Effect of age at diagnosis. Ann Epidemiol (1995) 0.87
[Fibrosing lupus erythematosus panniculitis in a pregnant woman with anti-RO/SSA antibodies in mother and child]. Ann Dermatol Venereol (1987) 0.86
Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays. J Pathol (1998) 0.85
Monoclonal antibody 83D4 immunoreactivity in human tissues: cellular distribution and microcytophotometric analysis of immunoprecipitates on tissue sections. Anticancer Res (1992) 0.85
Inflammatory breast carcinoma: an immunohistochemical study using monoclonal anti-pHER-2/neu, pS2, cathepsin, ER and PR. Anticancer Res (1992) 0.84
Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors. J Pathol (1993) 0.84
p53 quantitative immunocytochemical analysis in breast carcinomas. Hum Pathol (1995) 0.84
Familial risk of breast cancer and abortion. Cancer Detect Prev (1994) 0.84
Effect of interferon-alpha 2b on cryoglobulinemia related to hepatitis C virus infection. J Infect Dis (1992) 0.84
Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up. Br J Cancer (2007) 0.84
Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer. Int J Biol Markers (2003) 0.83
Oral contraceptives and breast cancer: a French case-control study. Int J Epidemiol (1991) 0.83
Diabetic mastopathy, complication of type 1 diabetes mellitus: report of two cases and a review of the literature. Diabetes Metab (1998) 0.82
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome. Br J Cancer (2009) 0.82
Infantile digital fibroma--report on eleven cases. Eur J Pediatr Surg (1997) 0.82
Specific xerostomia during Urbach-Wiethe disease. Dermatology (1994) 0.82
[Role of surgery in the strategy of primary local and regional treatment of stage I and II cancer of the endometrium]. J Gynecol Obstet Biol Reprod (Paris) (1986) 0.82
c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival. Br J Cancer (1997) 0.81
[Polycystic disease of the salivary glands: report of an attack of the submaxillary glands]. Ann Pathol (1998) 0.81
Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas. Br J Cancer (1997) 0.81
Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol (1988) 0.81
Impact of menopausal hormone-replacement therapy on clinical and laboratory characteristics of breast cancer. Int J Cancer (1998) 0.81
Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol (1994) 0.80
[Botryoid sarcoma of the cervix uteri. Review of the literature apropos of a case]. Rev Fr Gynecol Obstet (1966) 0.80
Bayesian population model of methotrexate to guide dosage adjustments for folate rescue in patients with breast cancer. J Clin Pharm Ther (2002) 0.80
Vaginal self-sampling is an adequate means of screening HR-HPV types in women not participating in regular cervical cancer screening. Clin Microbiol Infect (2012) 0.80
[Breast carcinoma diagnosed from surgical specimens. Retrospective study on three years]. Ann Chir Plast Esthet (2004) 0.79
Palmoplantar orthokeratotic filiform hyperkeratosis in a patient with associated Darier's disease. Classification of filiform hyperkeratosis. Dermatology (1992) 0.79
Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas. Int J Oncol (1998) 0.79
[Primary brain lymphomas. Anatomoclinical, ultrastructural and immunocytochemical study about 23 cases (author's transl)]. Ann Pathol (1981) 0.79
[Angioma-like cutaneous metastasis disclosing a hepatocarcinoma]. Ann Dermatol Venereol (1986) 0.78
E-cadherin and beta-catenin expression in breast medullary carcinomas. Int J Oncol (1999) 0.78
[4 cases of recurring jaundice in pregnancy]. Bull Fed Soc Gynecol Obstet Lang Fr (1971) 0.78
Familial risk of breast cancer in a French case-control study. Cancer Detect Prev (1994) 0.78
Secondary pancreatic involvement of mycosis fungoides detected by a clinically palpable mass. Dermatology (1994) 0.78
[The cost of breast cancer screening in France]. J Radiol (2000) 0.78
Quantitative immunocytochemical assays on frozen sections of p53: correlation to the follow-up of patients with breast carcinomas. Am J Clin Pathol (1996) 0.78
[Hirsutoid papilloma of the vulva]. Ann Dermatol Venereol (1987) 0.78
c-myc protein and Ki-67 antigen immunodetection in patients with uterine cervix neoplasia: correlation of microcytophotometric analysis and histological data. Gynecol Oncol (1993) 0.78
Correlation of nucleolar organizer regions and nuclear morphometry assessed by automatic image analysis in breast cancer with aneuploidy, K167 immunostaining, histopathologic grade and lymph node involvement. Pathol Res Pract (1992) 0.78